MP
ELV icon

Mangrove Partners’s Elevance Health ELV Stock Holding History

Mangrove Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,918
Closed -$1.91M – 399
2025
Q3 		$1.91M Buy
+5,918
New +$1.84M 0.14% 77
2017
Q3 		– Sell
-110,000
Closed -$20.7M – 32
2017
Q2 		$20.7M Hold
110,000
– – 4.22% 8
2017
Q1 		$18.2M Hold
110,000
– – 4.16% 9
2016
Q4 		$15.8M Buy
+110,000
New +$14.7M 2.85% 12

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Mangrove Partners's ELV Position: Q4 2025 in Review

Mangrove Partners sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 5,918 shares — an estimated $1.91M sold.

Mangrove Partners first reported a position in ELV in Q4 2016 and held it in 4 quarters. The position peaked at $20.7M in Q2 2017. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Mangrove Partners reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Mangrove Partners sold 5,918 Elevance Health shares in Q4 2025, an estimated $1.91M.
  • Mangrove Partners first reported a position in Elevance Health in Q4 2016 and held it in 4 quarters.
  • Mangrove Partners's Elevance Health position peaked at $20.7M in Q2 2017.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Mangrove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.